A European Respiratory Society research seminar on “Metabolic alterations in obstructive
sleep apnoea (OSA)” was jointly organised in October 2009 together with two EU COST …

Context Continuous positive airway pressure (CPAP) is the first-line treatment for patients
with symptomatic obstructive sleep apnea (OSA). However, its indication for all patients with …

To investigate the prevalence and behavior of sleep-related breathing disorders (SRBDs)
associated with a first-ever stroke or transient ischemic attack (TIA), we prospectively studied …

Importance More than 70% of patients with resistant hypertension have obstructive sleep
apnea (OSA). However, there is little evidence about the effect of continuous positive airway …

Background: The sleep apnea–hypopnea syndrome is defined by a pathologic number of
respiratory events during sleep (the apnea–hypopnea index, defined as the number of …

Rationale: Continuous positive airway pressure (CPAP) is the current treatment for patients
with symptomatic obstructive sleep apnea (OSA). Its use for all subjects with sleep …

The sleep medicine community has increasingly recognized the necessity that clinical care
be based on high-quality levels of evidence. Although research supports a favorable …

The sleep apnoea–hypopnoea syndrome is characterised by recurrent obstructions of the
upper airway, resulting in sleep disruption and arterial oxygen desaturations. Noninvasive …

Rationale: Obstructive sleep apnea (OSA) has been associated with increased cancer
mortality, but whether it is also associated with cancer incidence is unknown. Objectives: To …

Application of continuous positive airway pressure (CPAP) as the standard treatment for
sleep apnea/hypopnea syndrome (SAHS) is a moot point. Studies on the effectiveness of …